CN1068887C - Synthesis of affinity film medium using cellulose as substrate - Google Patents
Synthesis of affinity film medium using cellulose as substrate Download PDFInfo
- Publication number
- CN1068887C CN1068887C CN97101243A CN97101243A CN1068887C CN 1068887 C CN1068887 C CN 1068887C CN 97101243 A CN97101243 A CN 97101243A CN 97101243 A CN97101243 A CN 97101243A CN 1068887 C CN1068887 C CN 1068887C
- Authority
- CN
- China
- Prior art keywords
- reaction
- medium
- cellulose
- affinity
- carry out
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920002678 cellulose Polymers 0.000 title claims abstract description 35
- 239000001913 cellulose Substances 0.000 title claims abstract description 35
- 230000015572 biosynthetic process Effects 0.000 title description 6
- 238000003786 synthesis reaction Methods 0.000 title description 6
- 239000000758 substrate Substances 0.000 title description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 238000007142 ring opening reaction Methods 0.000 claims abstract description 12
- 239000011159 matrix material Substances 0.000 claims abstract description 8
- 230000007935 neutral effect Effects 0.000 claims abstract description 6
- 238000010189 synthetic method Methods 0.000 claims abstract 3
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000003999 initiator Substances 0.000 claims description 7
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 239000004593 Epoxy Substances 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- 239000004160 Ammonium persulphate Substances 0.000 claims 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 claims 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 claims 1
- 235000019395 ammonium persulphate Nutrition 0.000 claims 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 claims 1
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 claims 1
- 239000012528 membrane Substances 0.000 abstract description 20
- 238000000034 method Methods 0.000 abstract description 12
- 238000000926 separation method Methods 0.000 abstract description 10
- 238000000746 purification Methods 0.000 abstract description 9
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 abstract description 7
- 229920000642 polymer Polymers 0.000 abstract description 7
- 238000006116 polymerization reaction Methods 0.000 abstract description 7
- 125000003277 amino group Chemical group 0.000 abstract description 4
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 abstract description 4
- 238000009169 immunotherapy Methods 0.000 abstract description 3
- 125000003172 aldehyde group Chemical group 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 40
- 102000004169 proteins and genes Human genes 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 22
- 238000001179 sorption measurement Methods 0.000 description 16
- 229920000936 Agarose Polymers 0.000 description 12
- 239000002131 composite material Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 238000001042 affinity chromatography Methods 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- 239000012501 chromatography medium Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000011031 large-scale manufacturing process Methods 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 3
- 235000019345 sodium thiosulphate Nutrition 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical group NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 239000003547 immunosorbent Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- JHKIHARISAHZAK-UHFFFAOYSA-N 2-hydrazinylethanamine Chemical compound NCCNN JHKIHARISAHZAK-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920005372 Plexiglas® Polymers 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- -1 acrylic ester Chemical class 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000011140 membrane chromatography Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
一种以纤维素为基质的亲和膜介质的合成方法是采用以甲基丙烯酸环氧丙酯或丙烯酸环氧丙酯进行自聚反应得到聚合物,再与纤维素进行接枝反应,最后进行开环反应,得到活性基团为醛基或为氨基的亲和介质,自聚和技枝反应在中性介质中进行,反应温度为50~100℃,氨基的开环反应温度为40~80℃。按这种方法制备的亲和介质提高了纤维素的键合容量,并将在生物产品的大规模分离纯化及人体免疫治疗等方面有广阔的应用前景。A kind of synthetic method of the affinity membrane medium that takes cellulose as matrix is to adopt glycidyl methacrylate or glycidyl acrylate to carry out self-polymerization reaction to obtain polymer, carry out grafting reaction with cellulose again, carry out finally Ring-opening reaction to obtain an affinity medium in which the active group is an aldehyde group or an amino group. The self-polymerization and branching reaction is carried out in a neutral medium, and the reaction temperature is 50-100 ° C. The ring-opening reaction temperature of the amino group is 40-80 ℃. The affinity medium prepared by this method improves the binding capacity of cellulose, and will have broad application prospects in the large-scale separation and purification of biological products and human immunotherapy.
Description
本发明涉及一种以纤维素为基质的亲和膜介质的合成方法。具体地说是以纤维素为基质与甲基丙烯酸环氧丙酯共聚接枝合成复合介质,在此基础上开环氧化或开环接不同长度的间隔臂如氨基、乙二胺、肼等,合成可以连接带可反应基团的生物配基的亲和介质。The invention relates to a method for synthesizing an affinity membrane medium with cellulose as a matrix. Specifically, a composite medium is synthesized by copolymerization and grafting of cellulose as a substrate and glycidyl methacrylate, and on this basis, ring-opening oxidation or ring-opening is connected to spacer arms of different lengths such as amino, ethylenediamine, hydrazine, etc. Synthesis of affinity media that can attach bioligands with reactive groups.
近年来随着生物工程技术的发展,人们对生物制品的认识不断深入,需求不断增加,随之而来,各种用于生物制品纯化的分析分离方法得到了长足的发展。其中,亲和色谱由于特异性好、纯化倍数高等优点已成为分析蛋白质核酸等生物大分子的重要手段。目前,可用于做亲和介质的成分有琼脂糖、葡聚糖、纤维素、硅肢、聚丙烯酰胺类、多孔玻璃及各种高分子聚合物等。其中,琼脂糖是使用最早、应用最广泛的常压色谱介质,它结构均一,非特异性吸附极低,是非常好的色谱介质材料,在今后数年内,琼脂糖作为亲和色谱载体的主导地位很难被其它基质取代。但琼脂糖是一种凝胶类物质,即使进行交联,能承受的压力也极为有限。葡聚糖等胶质载体也一样,这样很难满足大规模制备的要求。Jaosoo J.C〖Agr.Foodchem.19(1971)581〗研究了Sephadex G150凝胶柱高流速与压降的关系,增加流速,压力随之增加,但到某一限度时流速减小,压降降低,这表明凝胶产生了不可逆变形,增加柱高,曲线拐点即允许流速降低,可见凝胶类基质难以放大生产,不能满足大规模制备要求。另一种常见的色谱介质硅胶,因其机械性能好,耐受压力高,尤其常见于高效亲和色谱中,但硅胶表面的硅羟基有部分离子性质,使得硅胶表面非特异性吸附强,且硅胶耐受pH范围较窄,限制了硅胶在亲和色谱中的应用。In recent years, with the development of bioengineering technology, people's understanding of biological products has continued to deepen, and the demand has continued to increase. Subsequently, various analytical separation methods for the purification of biological products have been greatly developed. Among them, affinity chromatography has become an important means of analyzing biological macromolecules such as proteins and nucleic acids due to its good specificity and high purification multiples. At present, the components that can be used as affinity media include agarose, dextran, cellulose, silicon limbs, polyacrylamides, porous glass, and various polymers. Among them, agarose is the earliest and most widely used normal-pressure chromatographic medium. It has a uniform structure and extremely low non-specific adsorption. It is a very good chromatographic medium material. In the next few years, agarose will be the dominant carrier of affinity chromatography It is difficult to be replaced by other substrates. However, agarose is a gel-like substance, and even if it is cross-linked, the pressure it can withstand is extremely limited. The same is true for colloidal carriers such as dextran, which is difficult to meet the requirements of large-scale production. Jaosoo J.C〖Agr.Foodchem.19(1971)581〗studied the relationship between the high flow rate and the pressure drop of Sephadex G150 gel column. When the flow rate increases, the pressure increases, but when the flow rate decreases to a certain limit, the pressure drop decreases. This shows that the gel has irreversible deformation, increasing the column height, and the inflection point of the curve is the allowable flow rate to decrease. It can be seen that the gel matrix is difficult to scale up and cannot meet the requirements of large-scale preparation. Another common chromatographic medium, silica gel, is especially common in high-efficiency affinity chromatography because of its good mechanical properties and high pressure resistance. However, the silanol on the surface of silica gel has some ionic properties, which makes the surface of silica gel strong non-specific adsorption, and silica gel The narrow pH range limits the application of silica gel in affinity chromatography.
近年来文献中虽然应用商品琼脂糖、硅胶等分离介质的很多,但作为介质研究已离开了单纯的琼脂糖、硅胶等传统介质,寻找复合介质成为亲和介质研究的一个方向。大规模制备中使用亲和介质具有如下要求:(1).成本低,(2)承受较高压力,(3)高亲和容量,(4)膨胀程度低,(5)压缩不变形。纤维素作为亲和介质机械性能好,化学稳定性高,是所有色谱介质中最廉价易得的原料,纤维素是大规模生产放大的首选亲和介质。但纤维素介质本身也有很大缺陷,这一缺陷限制了它在亲和色谱中的应用。主要是由纤维素的结构造成的。纤维素是由许多β-D-葡萄糖以1-4糖苷键连接成直链,直链间彼此平行,链间葡萄糖羟基可以形成氢键,这种非常有序的结构是纤维素的结晶区,离开这一结晶区的糖苷链则形成非结晶区。结晶区和非结晶区对亲和色谱制备的理化条件特别敏感,纤维素的衍生反应一般发生在结晶程度铰低或非结晶区,这样使得连接的配基在微观上相当不均匀,且可活化的基团含量远低于琼脂糖,使单纯的纤维素介质很难取得理想的亲和效果。In recent years, although commercial agarose, silica gel and other separation media have been widely used in the literature, the study of media has left the traditional media such as simple agarose and silica gel, and the search for composite media has become a direction of affinity media research. The use of affinity media in large-scale production has the following requirements: (1) low cost, (2) withstand high pressure, (3) high affinity capacity, (4) low degree of expansion, (5) no deformation under compression. As an affinity medium, cellulose has good mechanical properties and high chemical stability, and is the cheapest and easy-to-obtain raw material among all chromatographic media. Cellulose is the preferred affinity medium for large-scale production and amplification. However, the cellulose medium itself has great defects, which limit its application in affinity chromatography. Mainly caused by the structure of cellulose. Cellulose is composed of many β-D-glucose connected by 1-4 glycosidic bonds into straight chains, the straight chains are parallel to each other, and the hydroxyl groups of glucose between chains can form hydrogen bonds. This very ordered structure is the crystalline region of cellulose. Glycosidic chains leaving this crystalline region form the non-crystalline region. The crystalline and non-crystalline regions are particularly sensitive to the physical and chemical conditions of affinity chromatography. The derivatization reaction of cellulose generally occurs in the low-degree crystallization or non-crystalline regions, which makes the linked ligands quite heterogeneous microscopically and can be activated. The group content of cellulose is much lower than that of agarose, which makes it difficult to achieve the desired affinity effect with pure cellulose media.
本发明的目的是提供一种以纤维素为基质的亲和膜介质和合成方法。按这种方法制备的亲和介质大大提高了纤维素的键合容量。纤维素复合介质可以很方便的制膜,膜介质具有膨胀小、通透性好、耐压高、不易变形等优点。膜介质很容易填装成轴向柱及径向柱,轴向柱适用小规模的分离纯化,径向柱由于具有可线性放大、流速快等特点,适于大规模的分离纯化。该方法将在生物产品的大规模分离纯化及人体免疫治疗等方面有广阔的应用前景。The purpose of the present invention is to provide an affinity membrane medium and synthesis method with cellulose as the matrix. The affinity media prepared in this way greatly enhanced the binding capacity of cellulose. The cellulose composite medium can be easily formed into a membrane. The membrane medium has the advantages of small expansion, good permeability, high pressure resistance, and not easily deformed. Membrane media can be easily packed into axial columns and radial columns. Axial columns are suitable for small-scale separation and purification. Radial columns are suitable for large-scale separation and purification due to their linear amplification and fast flow rate. The method will have broad application prospects in the large-scale separation and purification of biological products and human immunotherapy.
为实现上述目的,本发明用纤维素与甲基丙烯酸环氧丙酯共聚接枝,使纤维素中不多的可衍生羟基与一条高分子链键合,这个高分子链中的每个单体含有一个可反应的活泼官能团,可大大提高纤维素的配基容量,并可通过改变聚合条件和键合条件使活泼官能团含量得到控制。活性基团含量1.0-2.5mmol/g(介质),解决了纤维素本身可衍生容量低的问题。同时由于纤维素表面聚集有高分子物质,使纤维素溶涨程度降低,又由于纤维素复合介质制膜方便,制成的膜介质通透性好,流速快,适于做生物大分子的大规模分离。上述本发明的合成亲和介质的方法,其特征在于采用以甲基丙烯酸环氧丙酯或丙烯酸环氧丙酯进行自聚得到聚合物,再与纤维素进行接枝反应,最后开环反应,得到活性基团为醛基或为氨基的亲和介质,自聚和接枝反应在中性介质中进行,反应温度为50~100℃,开环反应温度为40~80℃。同时,在自聚和接枝反应中要加入引发剂,例如偶氮二异丁腈,正丁基锂或过硫酸铵与硫代硫酸钠,引发剂加入量为反应单体重的1~5%。此外开环反应应控制在一定的pH值下进行,当开环反应物为己二胺时pH值为8~12。具体地说,本发明以纤维素为基质的亲和介质的制备由以下三步进行:In order to achieve the above object, the present invention uses cellulose and glycidyl methacrylate copolymerization grafting, so that the few derivatizable hydroxyl groups in the cellulose are bonded to a polymer chain, and each monomer in this polymer chain Containing a reactive active functional group can greatly increase the ligand capacity of cellulose, and the content of the active functional group can be controlled by changing the polymerization conditions and bonding conditions. The active group content is 1.0-2.5mmol/g (medium), which solves the problem of low derivatization capacity of cellulose itself. At the same time, due to the accumulation of high molecular substances on the surface of cellulose, the degree of swelling of cellulose is reduced, and because the cellulose composite medium is easy to form a membrane, the membrane medium produced has good permeability and fast flow rate, and is suitable for large biological macromolecules. scale separation. The above-mentioned method for synthesizing an affinity medium of the present invention is characterized in that it adopts glycidyl methacrylate or glycidyl acrylate to carry out self-polymerization to obtain a polymer, then carries out grafting reaction with cellulose, and finally ring-opening reaction, The affinity medium whose active group is aldehyde group or amino group is obtained, self-polymerization and grafting reaction are carried out in neutral medium, the reaction temperature is 50-100 DEG C, and the ring-opening reaction temperature is 40-80 DEG C. At the same time, an initiator, such as azobisisobutyronitrile, n-butyllithium or ammonium persulfate and sodium thiosulfate, should be added in the self-polymerization and grafting reactions, and the amount of the initiator added is 1 to 5% of the weight of the reaction monomer. . In addition, the ring-opening reaction should be controlled at a certain pH value, and the pH value is 8-12 when the ring-opening reactant is hexamethylenediamine. Specifically, the present invention takes cellulose as the preparation of the matrix-based affinity medium by the following three steps:
1.甲基丙烯酸环氧丙酯或丙烯酸环氧丙酯自聚成一定大小的聚合物;1. Glycidyl methacrylate or glycidyl acrylate self-polymerizes into polymers of a certain size;
2.纤维素与聚合物进行接枝反应;2. Grafting reaction between cellulose and polymer;
3.不同间隔臂长度的亲和介质的制备。3. Preparation of affinity media with different spacer arm lengths.
在上述1、2反应中,反应介质为中性水溶液,其中纤维素的含量为1.5~2.5%,甲基丙烯酸环氧丙酯或丙烯酸环氧丙酯的含量为3~10%,控制反应温度为50~100℃,自聚接枝反应时间以0.5~3小时为宜。在反应过程中要加入引发剂诱发反应,采用的阴离子聚合反应的引发剂为偶氮二异丁腈、止丁基锂或过硫酸铵与硫代硫酸钠,引发剂加入量为反应单体量的1~5%。氨基的开环反应在40~80℃下,并于一定的pH值下进行,具体的操作过程可按常规技术进行。下面通过实例对本发明的技术给予进一步地说明:In above-mentioned 1, 2 reaction, reaction medium is neutral aqueous solution, wherein the content of cellulose is 1.5~2.5%, the content of glycidyl methacrylate or glycidyl acrylate is 3~10%, control reaction temperature The temperature is 50-100°C, and the self-polymerization grafting reaction time is preferably 0.5-3 hours. In the reaction process, an initiator should be added to induce the reaction. The initiator of the anionic polymerization reaction used is azobisisobutyronitrile, butyllithium or ammonium persulfate and sodium thiosulfate, and the amount of the initiator added is the amount of the reaction monomer. 1-5% of the total. The ring-opening reaction of the amino group is carried out at 40-80°C and at a certain pH value, and the specific operation process can be carried out according to conventional techniques. Below by example the technology of the present invention is given further illustration:
实例1 复合介质的制备Example 1 Preparation of Composite Medium
自装自搅拌器、温度计及与凝器的250ml口烧瓶中,加水100ml,升温至80℃加入2克纤维素,充分搅拌均匀,加入5ml甲基丙烯酸环氧丙酯,搅5分钟后,加入含过硫酸铵与硫代硫酸钠各0.5克的混合溶液(约10ml),恒温反应2小时,停止反应,降至室温后用大量的水洗,再用丙酮或乙醇洗去纤维素表面的残余有机物,在真空烘箱中烘干,合成带有活性环氧基团的复合介质。复合介质中活性环氧基团的含量为1.0~2.5mmol/g(干介质)。Add 100ml of water to a 250ml flask with a self-installed mixer, thermometer and condenser, add 2 grams of cellulose when the temperature rises to 80°C, stir well, add 5ml of glycidyl methacrylate, stir for 5 minutes, add Contain a mixed solution (about 10ml) of 0.5 grams each of ammonium persulfate and sodium thiosulfate, react at a constant temperature for 2 hours, stop the reaction, wash with a large amount of water after cooling down to room temperature, and then wash off the residual organic matter on the surface of the cellulose with acetone or ethanol , and dried in a vacuum oven to synthesize a composite medium with active epoxy groups. The active epoxy group content in the composite medium is 1.0-2.5mmol/g (dry medium).
实例2 带有4个原子间隔臂的亲和介质的合成Example 2 Synthesis of an affinity medium with 4 atom spacers
用实例1所制备的环氧型复合介质置于pH=0.5的盐酸溶液中,均匀搅拌,使环氧充分开环成为邻位羟基,一般室温需要3天,检测不出介质中的环氧,中止反应,过滤,用水充分洗涤至中性,然后加入到新配制的1.5%碘酸钠(NalO4)中30分钟,过滤,大量水洗涤,制膜烘干。将膜介质装于小柱中进行接配基实验。将小柱用0.1mol/lpH=7.6的磷酸缓冲液平衡,取一定量的蛋白质溶于平衡缓冲液中,室温或4℃上样循环4小时或更长时间,用平衡缓冲液冲洗至A280无吸收,用0.1mol/lpH=8.2的硼酸缓冲液平衡,用甘氨酸乙酯盐酸盐溶液钝化1小时,再加入一定量的NaBH4或NaCHBH3还原碳氮键,还原12小时或更长时间,然后依次通过0.1mol/lpH=8.2的硼酸缓冲液,0.2mol/lpH=2.3的甘氨酸溶液,0.1mol/lpH=7.6含1mol/lNaCl的磷酸缓冲液,最后用0.1mol/lpH=7.6的磷酸缓冲液平衡,合成臂长为4个原子的亲和介质。The epoxy-type composite medium prepared in Example 1 is placed in a hydrochloric acid solution of pH=0.5, and stirred evenly, so that the epoxy is fully ring-opened to become an ortho hydroxyl group. Generally, it takes 3 days at room temperature, and the epoxy in the medium cannot be detected. Stop the reaction, filter, wash fully with water until neutral, then add to newly prepared 1.5% sodium iodate (NalO 4 ) for 30 minutes, filter, wash with a large amount of water, and dry the membrane. The membrane medium was packed in a small column for the ligand experiment. Equilibrate the small column with 0.1mol/l pH=7.6 phosphate buffer, take a certain amount of protein and dissolve it in the equilibrium buffer, load the sample at room temperature or 4°C for 4 hours or longer, and wash with the equilibrium buffer until A280 is free. Absorption, balance with boric acid buffer solution of 0.1mol/lpH=8.2, passivate with glycine ethyl ester hydrochloride solution for 1 hour, then add a certain amount of NaBH 4 or NaCHBH 3 to reduce carbon-nitrogen bond, and reduce for 12 hours or more , and then passed through 0.1mol/lpH=8.2 boric acid buffer, 0.2mol/lpH=2.3 glycine solution, 0.1mol/lpH=7.6 phosphate buffer containing 1mol/lNaCl, and finally 0.1mol/lpH=7.6 phosphoric acid Buffer equilibration, synthesis of affinity media with arm lengths of 4 atoms.
实例3:臂长为11个原子的亲和介质的合成Example 3: Synthesis of an affinity medium with an arm length of 11 atoms
用实例1所制备环氧型复合介质3克,加入150ml水中,强烈搅至分散均匀,升温至80℃后,加氨水10~30ml,控制pH值为8~12,回流1~2小时,抽滤至滤液中性。做膜装柱,0.1mol/l pH=8.2的硼酸缓冲液平衡,用一定量0.25%戊二醛溶液循环2小时,通过2mol/l醋酸溶液,用纯水洗至A280无吸收,用0.1mol/l pH=7.6的磷酸缓冲液平衡,键合配基步骤同实例1。合成臂长为11个原子的亲和介质。Use 3 grams of the epoxy-type composite medium prepared in Example 1, add 150ml of water, stir vigorously until the dispersion is even, after heating up to 80°C, add 10-30ml of ammonia water, control the pH value to 8-12, reflux for 1-2 hours, pump Filter until the filtrate is neutral. Make a membrane column, equilibrate with 0.1mol/l boric acid buffer solution with pH=8.2, circulate with a certain amount of 0.25% glutaraldehyde solution for 2 hours, pass through 2mol/l acetic acid solution, wash with pure water until A280 has no absorption, and use 0.1mol/l l Phosphate buffer with pH=7.6 is equilibrated, and the procedure for binding ligands is the same as in Example 1. Affinity media with arms length 11 atoms were synthesized.
实例4:臂长为18个原子的亲和介质的合成Example 4: Synthesis of an affinity medium with an arm length of 18 atoms
用实例1所制备的环氧型复合介质3克,加入150ml水中,强烈搅拌至分散均匀,升温至80℃后,加入相当于环氧含量1~5倍的乙二胺固体,控制pH值为8~12,反应1~2小时,取出洗涤至中性,做膜烘干装柱,用戊二醛活化及接配基步骤同实例1,合成臂长为18个原子的亲和介质。Add 3 grams of the epoxy-type composite medium prepared in Example 1 into 150ml of water, stir vigorously until the dispersion is uniform, and after heating up to 80°C, add ethylenediamine solids equivalent to 1 to 5 times the epoxy content, and control the pH to 8 to 12, react for 1 to 2 hours, take out and wash to neutrality, make a membrane, dry and pack into a column, activate with glutaraldehyde and attach a ligand. The steps are the same as in Example 1, and the synthetic arm length is 18 atoms.
比较例1Comparative example 1
用本发明技术制备的QHprotein A吸附柱与美国CUNO公司生产的ZETAFINITY-10 protein A吸附柱的比较Comparison of the QHprotein A adsorption column prepared by the technology of the present invention and the ZETAFINITY-10 protein A adsorption column produced by the U.S. CUNO company
(1)实验材料及方法(1) Experimental materials and methods
实验中使用的小牛血清白蛋白为电泳纯,IgG为免疫纯,均购自华美生化试剂公司。所用的泵为Cole Parmer model 7518-10,检测器为GILSONmodel 112紫外检测器,检测波长254(in)/280(out),Sensitivity(AUFS)1.0,KNUER计录仪,纸速1.0mm/分。752C型紫外可见分光光度计(上海第二分析仪器厂产)。蛋白浓度测定:A280紫外检测法,用小牛血清白蛋白标准浓度曲线测定。The bovine serum albumin used in the experiment was electrophoretic pure, and the IgG was immunologically pure, both purchased from Huamei Biochemical Reagent Company. The pump used is Cole Parmer model 7518-10, the detector is GILSON model 112 ultraviolet detector, the detection wavelength is 254 (in)/280 (out), Sensitivity (AUFS) 1.0, KNUER recorder, paper speed 1.0mm/min. 752C UV-Vis spectrophotometer (produced by Shanghai No. 2 Analytical Instrument Factory). Determination of protein concentration: A280 ultraviolet detection method, determined by bovine serum albumin standard concentration curve.
(2)QH protein A柱与ZETA-10 protein A柱简介(2) Brief introduction of QH protein A column and ZETA-10 protein A column
QH protein A柱:膜介质按本发明的技术方法合成,柱尺寸为8×20mmI.D.,介质重量1.04g,流量为4ml/分时,柱前压力为10psi。柱子外壳为有机玻璃,ZETA-10protein A柱:介质为以纤维素为基质合成的亲和介质,尺寸为38×10mmI.D.,可装介质0.9~1.0g,柱子外壳为塑料制品,当流量为3ml/min时,柱压增大,柱子极易破裂。QH protein A column: The membrane medium is synthesized according to the technical method of the present invention, the column size is 8×20mmI.D., the medium weight is 1.04g, and when the flow rate is 4ml/min, the pre-column pressure is 10psi. The column shell is plexiglass, ZETA-10protein A column: the medium is an affinity medium synthesized with cellulose as the matrix, the size is 38×10mmI.D., and the medium can hold 0.9~1.0g. The column shell is made of plastic products. When the pressure is 3ml/min, the column pressure increases and the column is easily broken.
(3)对人lgG最大吸附量的比较(3) Comparison of the maximum adsorption capacity of human IgG
人lgG溶于0.01mol/pH=7.5磷酸缓冲液中,浓度10.6mg/ml,取4ml上柱,循环10分钟,用平衡缓冲液冲洗记录仪基线,用0.2mol/l pH-2.3甘氨酸缓冲液洗脱至基线,收集洗脱液,测浓度和体积。两柱上样量及处理方法完全相同,其结果为采用QH protein A柱和ZETA-10 protein A柱时,其对人lgG最大吸附容量分别分32.0mg/g干介质和12.0mg/g干介质。Human IgG was dissolved in 0.01mol/pH=7.5 phosphate buffer, the concentration was 10.6mg/ml, 4ml was put on the column, circulated for 10 minutes, the baseline of the recorder was washed with equilibrium buffer, and 0.2mol/l pH-2.3 glycine buffer was used Elute to the baseline, collect the eluate, and measure the concentration and volume. The sample loading and processing methods of the two columns are exactly the same. The result is that when the QH protein A column and the ZETA-10 protein A column are used, the maximum adsorption capacity for human IgG is 32.0mg/g dry medium and 12.0mg/g dry medium respectively .
(4)最大非特异吸附容量的比较(4) Comparison of maximum non-specific adsorption capacity
将小牛血清白蛋白溶于0.01mol/l pH=7.5磷酸缓冲液中,浓度1mg/ml,取4ml上样循环10分钟,用平衡缓冲液冲洗记录仪基线,用pH=7.5mol/lNaCl洗脱至基线,收集洗脱液,测浓度和体积,两柱上样量及处理方法完全相同,其结果为采用QH protein A柱和ZETA-10 protein A柱,其最大非特异吸附容量分别为1.30mg/g干介质和2.11mg/g干介质。Dissolve bovine serum albumin in 0.01mol/l pH=7.5 phosphate buffer with a concentration of 1mg/ml, take 4ml of sample and cycle for 10 minutes, wash the baseline of the recorder with equilibrium buffer, and wash with pH=7.5mol/l NaCl Remove to the baseline, collect the eluate, measure the concentration and volume, the loading and processing methods of the two columns are exactly the same, the result is that the QH protein A column and ZETA-10 protein A column are used, and the maximum non-specific adsorption capacity is 1.30 mg/g dry medium and 2.11 mg/g dry medium.
比较例2Comparative example 2
用于免疫吸附治疗的protein A膜吸附柱与proteinA琼脂糖吸附柱的比较。Comparison of protein A membrane adsorption columns and protein A agarose adsorption columns for immunosorbent therapy.
免疫吸附疗法是通过抗原抗体免疫反应或物理化学作用去除人血液中的内原性、外原性致病因子,净化血液,从而达到治疗某些疑骓病症的目的。近些年来,免疫吸附治疗已逐渐成为血液净化技术的重要分枝,日益引起医学界的关注。现在已用于临床治疗效果较好的是A蛋白。目前,已经有商品出售的是瑞典Gambro公司生产的以琼脂糖为基质的A蛋白免疫吸附柱。此柱含琼脂量为62.5ml,A蛋白结合能力为20mgIgG/ml琼脂,外壳由丙烯酸酯包成50×40mm的圆柱形,血浆灌流速度为15~35ml/分,目前以纤维素为基质的商品免疫吸附柱还未见报道。用本发明的技术方法合成了间隔臂长度为18个原子的Protein A免疫吸附柱。柱子形式分两种,一种是轴向柱,尺寸为14×60mm,I.D,装介质12g,血浆灌流速度为20~80ml/分,A蛋白结合能力为32mg lgG/g干介质,另一种柱形式为径向柱,它是采用螺旋卷式膜组件结构,液体由柱外围流向柱芯,尺寸为20×60mmI.D.,内装介质13g,血浆灌流速度为20~200ml/分,A蛋白结合能力不变。正常人血浆通过上述A蛋白膜吸附柱,吸附上的lgG用pH=2.3的甘氨酸=HCL缓冲液洗脱下来,做质谱检验共纯度,结果表明,采用本发明的技术制备的protein A膜吸附柱特异性较好。proteinA膜吸附柱经过去菌,去热原处理,临床动物实验效果较好。Immunoadsorption therapy is to remove endogenous and exogenous pathogenic factors in human blood through antigen-antibody immune reaction or physical and chemical action, and purify the blood, so as to achieve the purpose of treating some suspected diseases. In recent years, immunoadsorption therapy has gradually become an important branch of blood purification technology, and has increasingly attracted the attention of the medical community. It is protein A that has been used in clinical treatment with better effect. At present, what has been commercially sold is the protein A immunoadsorption column with agarose as the matrix produced by Gambro Company of Sweden. This column contains 62.5ml of agar, the binding capacity of protein A is 20mgIgG/ml agar, the shell is made of acrylic ester into a cylindrical shape of 50×40mm, and the plasma perfusion rate is 15-35ml/min. Immunoadsorption column has not been reported yet. A protein A immunoadsorption column with a spacer arm length of 18 atoms was synthesized by the technical method of the present invention. There are two types of columns, one is the axial column, the size is 14×60mm, I.D, the medium is 12g, the plasma perfusion rate is 20-80ml/min, the protein A binding capacity is 32mg lgG/g dry medium, the other is The column is in the form of a radial column, which adopts a spiral-wound membrane module structure. The liquid flows from the periphery of the column to the column core. The size is 20×60mmI.D., and the inner medium is 13g. The ability to bind remains unchanged. Normal human plasma passes through the above protein A membrane adsorption column, and the adsorbed IgG is eluted with glycine=HCL buffer solution with pH=2.3, and the co-purity is checked by mass spectrometry. The results show that the protein A membrane adsorption column prepared by the technology of the present invention Good specificity. The proteinA membrane adsorption column has been sterilized and depyrogenated, and the clinical animal experiment effect is good.
由以上比较可以看出,用本发明的技术制备的protein A免疫吸附柱吸附容量比美国CUNO公司的ZETA-10protein A柱高出近2倍,单位体积的吸附容量相当于以琼脂糖为基质的protein A吸附柱的二分之一,但其流量要明显高于琼脂糖柱。As can be seen from the above comparison, the adsorption capacity of the protein A immunosorbent column prepared by the technology of the present invention is nearly 2 times higher than that of the ZETA-10protein A column of the U.S. CUNO company, and the adsorption capacity per unit volume is equivalent to the agarose-based column. One-half of the protein A adsorption column, but its flow rate is significantly higher than that of the agarose column.
上述实例和比较例的结果表明,本发明的技术方法合成的亲和膜介质避开了琼脂糖等软基质的弱点,具有较强的耐压性,介质以膜的形式存在柱中,在较高的流速下仍能稳定存在,在短时间内就可完成分离操作,大分子以对流的方式在膜空隙中流动,能很快与配基结合,改善了柱中传质,从理论上讲,径向膜色谱具有可线性方大的特点,适于大规模的分离纯化。该方法将在生物产品的大规模分离纯化及人体免疫治疗等方面有广阔的应用前景。The results of the above examples and comparative examples show that the synthetic affinity membrane medium of the technical method of the present invention avoids the weakness of soft substrates such as agarose, and has strong pressure resistance. It can still exist stably at a high flow rate, and the separation operation can be completed in a short time. The macromolecule flows in the membrane gap in a convective manner, and can quickly combine with the ligand, which improves the mass transfer in the column. Theoretically speaking , radial membrane chromatography has the characteristics of linearity and large size, and is suitable for large-scale separation and purification. The method will have broad application prospects in the large-scale separation and purification of biological products and human immunotherapy.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97101243A CN1068887C (en) | 1997-02-25 | 1997-02-25 | Synthesis of affinity film medium using cellulose as substrate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97101243A CN1068887C (en) | 1997-02-25 | 1997-02-25 | Synthesis of affinity film medium using cellulose as substrate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1191866A CN1191866A (en) | 1998-09-02 |
| CN1068887C true CN1068887C (en) | 2001-07-25 |
Family
ID=5165604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97101243A Expired - Fee Related CN1068887C (en) | 1997-02-25 | 1997-02-25 | Synthesis of affinity film medium using cellulose as substrate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1068887C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107790108B (en) * | 2017-10-31 | 2020-07-14 | 苏州博进生物技术有限公司 | Affinity chromatography medium using hollow zinc oxide microspheres as rigid matrix |
| CN107866206B (en) * | 2017-10-31 | 2020-07-31 | 苏州博进生物技术有限公司 | Epoxy activated affinity chromatography medium |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4788288A (en) * | 1985-07-30 | 1988-11-29 | Air Products And Chemicals, Inc. | Self-and Hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers |
| CN1072969A (en) * | 1992-10-05 | 1993-06-09 | 中国科学院广州化学研究所 | The viscose grafting, copolymerization and modification prepares the wool-like fiber method |
-
1997
- 1997-02-25 CN CN97101243A patent/CN1068887C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4788288A (en) * | 1985-07-30 | 1988-11-29 | Air Products And Chemicals, Inc. | Self-and Hydroxyl reactive formaldehyde-free cyclic hemiamidal and hemiamide ketal crosslinking monomers |
| CN1072969A (en) * | 1992-10-05 | 1993-06-09 | 中国科学院广州化学研究所 | The viscose grafting, copolymerization and modification prepares the wool-like fiber method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1191866A (en) | 1998-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mallik et al. | High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns | |
| CA2938544C (en) | Novel affinity chromatography media for removal of anti-a and/or anti-b antibodies | |
| JP5826180B2 (en) | Separation matrix | |
| CN102343257B (en) | Process for making improved chromatography media and method of use | |
| AU2006327328B2 (en) | Preparation of biomolecules | |
| JP7584481B2 (en) | Composite Materials for Bioseparation | |
| Phillips | Analytical techniques in immunochemistry | |
| JP3722842B2 (en) | Method for separating PTH-amino acids | |
| WO2019039545A1 (en) | Chromatography carrier, ligand-immobilizing carrier, chromatography column, target substance purification method, and chromatography carrier production method | |
| JPWO1998033064A1 (en) | Method for separating PTH-amino acids | |
| CN101464439B (en) | A kind of preparation method of protein molecular imprinting monolithic column | |
| CN1068887C (en) | Synthesis of affinity film medium using cellulose as substrate | |
| WO2013187512A1 (en) | Alkali-resistant ion exchange temperature-responsive adsorbent, and method for producing same | |
| CN103333299A (en) | Glycidyl methacrylate and poly (glycol) methacrylate copolymer microsphere, preparation method and application of copolymer microsphere | |
| JPH02104289A (en) | New colored monomer and polymer, production of said polymer and separation of biologically active substance using said polymer | |
| Cattoli et al. | Separation of MBP fusion proteins through affinity membranes | |
| CN108570118B (en) | A kind of affinity chromatography purification method of placenta-like chondroitin sulfate A or its derivatives | |
| CN114534310B (en) | Composite anion chromatography medium and preparation method and application thereof | |
| CN120965875B (en) | Nanobody 4C12 and application thereof in promoting purification of human albumin | |
| Wulan et al. | Enhancement of microsphere specificity to purify human serum albumin from blood plasma | |
| Gai et al. | Preparation of bovine hemoglobin-imprinted polymer beads via the photografting surface-modified method | |
| JPS62227446A (en) | Adsorbent for affinity chromatography | |
| US5576175A (en) | Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen | |
| RU2736149C1 (en) | Method n1 for preparing a sorbent based on covalent immobilized and chemically modified lysozyme for sorption of bacterial endotoxins and the sorbent itself | |
| Poddar | Entrapment of Ligands in High-Performance Affinity Columns for Chromatographic Studies of Solute-Ligand Interaction and Use of Sandwich Immunoassay for Antibody Detection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1036420 Country of ref document: HK |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |